P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy.

Prado, Guy F A; Beraldo de Andrade, Pedro; Garzon Dias Lemos, Stefano; Franken, Marcelo; Oliveira Guimaraes, Patricia; de Assis Moura Tavares, Caio; Grunspun Pitta, Fabio; Mateus Teixeira Bezerra, Felipe; Carlos Bandeira, Willterson; Sanali, Maria; Regina Lamas Assis, Silvia; Monfardini, Frederico; de Carvalho Abrão, Lailah Cristina; Coura Rocha, Rosana; Mangione, Fernanda; Arantes Pazolini, Vitor; Justi Bertolin, Adriadne; Antunes, Murillo; Serra Silveira, Fabio; Nascimento, Bruno Ramos; Ohe, Louis N; Ferreira, Esmeralci; Sampaio, Fernanda B A; Sarmento-Leite, Rogerio; Wainstein, Marco V; Guedes Bezerra, Cristiano; Airton Arruda, Jose; Oliveira Almeida, Breno; Paradies, Valeria; Mariani Junior, Jose; Alves Lemos Neto, Pedro

doi:10.4244/EIJ-D-26-00409

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy.

2026-07-20, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (10.4244/EIJ-D-26-00409) (online)
Guy F A Prado, Pedro Beraldo de Andrade, Stefano Garzon Dias Lemos, Marcelo Franken, Patricia Oliveira Guimaraes, Caio de Assis Moura Tavares, Fabio Grunspun Pitta, Felipe Mateus Teixeira Bezerra, Willterson Carlos Bandeira, Maria Sanali, Silvia Regina Lamas Assis, Frederico Monfardini, Lailah Cristina de Carvalho Abrão, Rosana Coura Rocha, Fernanda Mangione, Vitor Arantes Pazolini, Adriadne Justi Bertolin, Murillo Antunes, Fabio Serra Silveira, Bruno Ramos Nascimento, Louis N Ohe, Esmeralci Ferreira, Fernanda B A Sampaio, Rogerio Sarmento-Leite, Marco V Wainstein, Cristiano Guedes Bezerra, Jose Airton Arruda, Breno Oliveira Almeida, Valeria Paradies, Jose Mariani Junior, and Pedro Alves Lemos Neto (?)

Whether the anatomical complexity of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) influences the effects of antiplatelet therapy remains unknown.

This article has not yet been included in any curations.

Comments

There are no comments on this article yet.

You need to login or register to comment.

BioSothis

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy after complex percutaneous coronary intervention in patients with acute coronary syndromes: a NEO-MINDSET trial substudy.